Results
|
1.
|
First Report of Edge Vascular Response at 12Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study. MedStar authors:
- Azizi, Viana
- Dan, Kazuhiro
- Garcia-Garcia, Hector M
- Hideo-Kajita, Alexandre
- Kuku, Kayode
- Ozaki, Yuichi
- Waksman, Ron
Year: 2019
Citation: - Cardiovascular Revascularization Medicine. 20(5):392-398, 2019 05.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Azizi V, Christiansen EH, Dan K, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Hideo-Kajita A, Ince H, Joner M, Kaiser C, Koolen J, Kuku KO, Lemos PA, Neumann FJ, Ozaki Y, Teik LS, Toelg R, von Birgelen C, Waksman R, Wijns W
|
|
2.
|
Serum Magnesium Levels and Outcomes in Patients With Acute Spontaneous Intracerebral Hemorrhage. MedStar authors:
Year: 2018
Citation: - Journal of the American Heart Association. 7(8), 2018 Apr 13
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Alexandrov AV, Alsherbini K, Arthur AS, Chang JJ, Elijovich L, Goyal N, Houck AL, Inoa V, Khorchid YM, Malhotra K, Pandhi A, Tsivgoulis G
|
|
3.
|
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors:
Year: 2016
Citation: - Lancet. 387(10013):31-9, 2016 Jan 2.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W
|
|
4.
|
|
|
5.
|
|
|
6.
|
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Lancet. 381(9869):836-44, 2013 Mar 9.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Bose D, Degen H, Erbel R, Erne P, Haude M, Koolen J, Prati F, Verheye S, Vermeersch P, Waksman R, Weissman N, Wijnbergen I
|